LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all patients with CLL require therapy. Irrespective of all latest innovations, the iwCLL nonetheless recommends watchful observation for people with asymptomatic ailment.86 This suggestion is predicated on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).